期刊文献+

奥拉西坦残留溶剂的测定 被引量:4

Determination of residual solvents in oxiracetam
在线阅读 下载PDF
导出
摘要 目的:建立奥拉西坦原料药中甲醇、乙醇、二氯甲烷、正己烷、环己烷、甲苯、二甲苯和苯八类残留溶剂的测定方法。方法:采用毛细管柱色谱直接进样法,色谱柱DB-624型毛细管柱,柱温采用程序升温,检测器为氢火焰离子化检测器,载气为氮气,柱流量为1.0 mL·min^(-1)。结果:8种溶剂均获得基线分离,浓度范围内与峰面积线性关系良好,每个残留溶剂组分平均回收率均符合要求。测定样品3批,甲醇含量均为0.01%,其他七种残留溶剂均未检出。结论:本法专属性强、重复性好、结果可靠、适用于奥拉西坦原料药中残留溶剂的测定。 Objective:To establish a method for the determination of residual solvents in methanol,ethanol,dichloromethane,n-hexane,cyclohexane,toluene,xylene and benzene in oxiracetam raw materials.Methods:Using capillary column chromatography direct injection method,chromatographic column DB-624 capillary column,the column temperature adopts programmed temperature rise,the detector was a hydrogen flame ionization detector,the carrier gas was nitrogen,and the column flow rate was 1.0 mL·min^(-1).Results:Baseline separation was obtained for all 8 solvents,and the linear relationship with peak area was good within the concentration range,and the average recovery rate of each residual solvent component met the requirements.Three batches of samples were tested,the methanol content was 0.01%,and the other seven residual solvents were not detected.Conclusion:This method has strong specificity,good repeatability and reliable results,and is suitable for the determination of residual solvents in oxiracetam raw materials.
作者 王晔 WANG Ye(Anhui Institute for Food and Drug Control,Hefei 230051,China)
出处 《中国药品标准》 CAS 2022年第5期525-528,共4页 Drug Standards of China
关键词 奥拉西坦 羟基氨基酸丁酸环状衍生物 神经病变 磷酰乙醇胺 磷酰胆碱 残留溶剂 oxiracetam hydroxyamino acid butyric acid cyclic derivative neuropathy phosphorylethanolamine phosphorylcholine residual solvent
  • 相关文献

参考文献2

二级参考文献32

  • 1屠鹏飞,贾存勤,张洪全.大孔吸附树脂在中药新药研究和生产中的应用[J].世界科学技术-中医药现代化,2004,6(3):22-28. 被引量:74
  • 2Parnetti L, Mecocci P, Gaiti A, et al. Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type [J]. Eur J Drug Metab Pharmacokinet, 1990, 15(1): 75-78.
  • 3Ponzio F, Pozzi O, Banfi S, et al. Brain entry and direct central pharmacological effects of the nootropic drug oxiracetam. Oxiracetam: brain entry and pharmacological effects [J]. Pharmacopsychiatry, 1989, 22(Suppl 2): 111-115.
  • 4Banfi S, Dorigotti L, Abbracchio MP, et al. Methylazoxymethanol microencephaly in rats: neurochemical characterization and behavioral studies with the nootropic oxiracetam [J]. Pharmacol Res Commun, 1984, 16(1): 67-83.
  • 5Lecaillon JB, Dubois JP, Coppens H, et al. Pharmacokinetics of oxiracetam in elderly patients after 800 mg oral doses, comparison with non-geriatric healthy subjects [J]. Eur J Drug Metab Pharmacokinet, 1990, 15(3): 223-230.
  • 6Pepeu G, Spignoli G. Nootropic drugs and brain cholinergic mechanisms [J]. Prog Neuropsychopharmacol Biol Psychiatry, 1989, 13(Suppl): S77-88.
  • 7Spignoli G, Pepeu G. Oxiracetam prevents electroshock-induced decrease in brain acetylcholine and amnesia [J]. Eur J Pharmacol, 1986, 126(3): 253-257.
  • 8Spignoli G, Pepeu G. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine [J]. Pharmacol Biochem Behav, 1987, 27(3): 491-495.
  • 9Spignoli G, Pedata F, Giovannelli L, et al. Effect of oxiracetam and piracetam on central cholinergic mechanisms and active-avoidance acquisition [J]. Clin Neuropharmacol, 1986, 9(Suppl 3): S39-47.
  • 10Mochizuki D, Sugiyama S, Shinoda Y. Biochemical studies of oxiracetam (CT-848) on cholinergic neurons [J]. Nippon Yakurigaku Zasshi, 1992, 99(1): 27-35.

共引文献81

同被引文献58

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部